English

BIOTRANSPLANT INC

EDGAR

Quarterly report (10-Q) · filed 2002-11-19

30 filing records in this dataset, filed from 1996-06-20 to 2002-11-19. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

345 thousand USD

2002-09-30 · USD

Exact inputs and evidence

Revenue: 344588 USD Source

Operating margin

-1,505.59%

2002-09-30 · %

Exact inputs and evidence

Operating Income: -5188086 USD Source
Revenue: 344588 USD Source

Operating cash flow

-4.46 million USD

2002-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -14151586 USD Source
Operating Cash Flow: -9688317 USD Source

Free cash flow

-4.47 million USD

2002-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -14151586 USD Source
Operating Cash Flow: -9688317 USD Source
Capital Expenditure: 347210 USD Source
Capital Expenditure: 338125 USD Source

Cash and cash equivalents: 2.03 million USD 2002-09-30 Source
Exact value

2025762 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

1.69 million USD

2001-10-01 – 2002-09-30

Exact inputs and evidence

Revenue: 689773 USD · 2001-01-01 – 2001-12-31 Source
Revenue: 211997 USD · 2001-01-01 – 2001-09-30 Source
Revenue: 476616 USD · 2002-01-01 – 2002-03-31 Source
Revenue: 392731 USD · 2002-04-01 – 2002-06-30 Source
Revenue: 344588 USD · 2002-07-01 – 2002-09-30 Source

Net income

-43.9 million USD

2001-10-01 – 2002-09-30

Exact inputs and evidence

Net income: -42645591 USD · 2001-01-01 – 2001-12-31 Source
Net income: -34634458 USD · 2001-01-01 – 2001-09-30 Source
Net income: -6618095 USD · 2002-01-01 – 2002-03-31 Source
Net income: -24083168 USD · 2002-04-01 – 2002-06-30 Source
Net income: -5169562 USD · 2002-07-01 – 2002-09-30 Source

Operating cash flow

-17.1 million USD

2001-10-01 – 2002-09-30

Exact inputs and evidence

Operating cash flow: -13115605 USD · 2001-01-01 – 2001-12-31 Source
Operating cash flow: -10178324 USD · 2001-01-01 – 2001-09-30 Source
Operating cash flow: -4095142 USD · 2002-01-01 – 2002-03-31 Source
Operating cash flow: -9688317 USD · 2002-01-01 – 2002-06-30 Source
Operating cash flow: -4095142 USD · 2002-01-01 – 2002-03-31 Source
Operating cash flow: -14151586 USD · 2002-01-01 – 2002-09-30 Source
Operating cash flow: -9688317 USD · 2002-01-01 – 2002-06-30 Source

Capital expenditure

1.09 million USD

2001-10-01 – 2002-09-30

Exact inputs and evidence

Capital expenditure: 1137350 USD · 2001-01-01 – 2001-12-31 Source
Capital expenditure: 394036 USD · 2001-01-01 – 2001-09-30 Source
Capital expenditure: 258054 USD · 2002-01-01 – 2002-03-31 Source
Capital expenditure: 338125 USD · 2002-01-01 – 2002-06-30 Source
Capital expenditure: 258054 USD · 2002-01-01 – 2002-03-31 Source
Capital expenditure: 347210 USD · 2002-01-01 – 2002-09-30 Source
Capital expenditure: 338125 USD · 2002-01-01 – 2002-06-30 Source

Free cash flow

-18.2 million USD

2001-10-01 – 2002-09-30

Exact inputs and evidence

Operating cash flow: -13115605 USD · 2001-01-01 – 2001-12-31 Source
Operating cash flow: -10178324 USD · 2001-01-01 – 2001-09-30 Source
Operating cash flow: -4095142 USD · 2002-01-01 – 2002-03-31 Source
Operating cash flow: -9688317 USD · 2002-01-01 – 2002-06-30 Source
Operating cash flow: -4095142 USD · 2002-01-01 – 2002-03-31 Source
Operating cash flow: -14151586 USD · 2002-01-01 – 2002-09-30 Source
Operating cash flow: -9688317 USD · 2002-01-01 – 2002-06-30 Source
Capital expenditure: 1137350 USD · 2001-01-01 – 2001-12-31 Source
Capital expenditure: 394036 USD · 2001-01-01 – 2001-09-30 Source
Capital expenditure: 258054 USD · 2002-01-01 – 2002-03-31 Source
Capital expenditure: 338125 USD · 2002-01-01 – 2002-06-30 Source
Capital expenditure: 258054 USD · 2002-01-01 – 2002-03-31 Source
Capital expenditure: 347210 USD · 2002-01-01 – 2002-09-30 Source
Capital expenditure: 338125 USD · 2002-01-01 – 2002-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2002-11-19.

Financial data available through: 2001-12-31.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 2001-12-31
Operating income: 3 of 11 periods available· newest 2001-12-31
Net income: 6 of 11 periods available· newest 2001-12-31
Operating cash flow: 5 of 11 periods available· newest 2001-12-31
Capital expenditure: 5 of 11 periods available· newest 2001-12-31
Total assets: 6 of 11 periods available· newest 2001-12-31
liabilities: No compatible figures in this window
Current assets: 6 of 11 periods available· newest 2001-12-31
Current liabilities: 6 of 11 periods available· newest 2001-12-31
Cash and cash equivalents: 6 of 11 periods available· newest 2001-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-84.9%

Prior period

USD 4.56 million

2000-01-01 – 2000-12-31
Current period

USD 689,773

2001-01-01 – 2001-12-31

Exact inputs and evidence

689773 − 4563475 = -3873702 USD

4563475 USD · 2000-01-01 – 2000-12-31
Inspect prior input Prior source
689773 USD · 2001-01-01 – 2001-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · BIOTRANSPLANT INC · 2001-12-31 BIOTRANSPLANT INC (edgar:880259) Year-over-year change in Revenue: -3873702 USD Concept: fundies:Revenue Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/880259?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 689773 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/880259/0000912057-02-010026.txt#2819 Input fundies:Revenue: 4563475 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/880259/0000912057-02-010026.txt#2819
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 30.97 million

Prior period

−USD 11.68 million

2000-01-01 – 2000-12-31
Current period

−USD 42.65 million

2001-01-01 – 2001-12-31

Exact inputs and evidence

-42645591 − -11679363 = -30966228 USD

-11679363 USD · 2000-01-01 – 2000-12-31
Inspect prior input Prior source
-42645591 USD · 2001-01-01 – 2001-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · BIOTRANSPLANT INC · 2001-12-31 BIOTRANSPLANT INC (edgar:880259) Year-over-year change in Net income: -30966228 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/880259?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -42645591 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/880259/0000912057-02-010026.txt#2940 Input fundies:NetIncome: -11679363 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/880259/0000912057-02-010026.txt#2940
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 3.29 million

Prior period

−USD 16.41 million

2000-01-01 – 2000-12-31
Current period

−USD 13.12 million

2001-01-01 – 2001-12-31

Exact inputs and evidence

-13115605 − -16410434 = 3294829 USD

-16410434 USD · 2000-01-01 – 2000-12-31
Inspect prior input Prior source
-13115605 USD · 2001-01-01 – 2001-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · BIOTRANSPLANT INC · 2001-12-31 BIOTRANSPLANT INC (edgar:880259) Year-over-year change in Operating cash flow: 3294829 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/880259?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -13115605 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/880259/0000912057-02-010026.txt#2959 Input fundies:OperatingCashFlow: -16410434 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/880259/0000912057-02-010026.txt#2959
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+280.2%

Prior period

USD 299,114

2000-01-01 – 2000-12-31
Current period

USD 1.14 million

2001-01-01 – 2001-12-31

Exact inputs and evidence

1137350 − 299114 = 838236 USD

299114 USD · 2000-01-01 – 2000-12-31
Inspect prior input Prior source
1137350 USD · 2001-01-01 – 2001-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · BIOTRANSPLANT INC · 2001-12-31 BIOTRANSPLANT INC (edgar:880259) Year-over-year change in Capital expenditure: 838236 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/880259?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 1137350 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/880259/0000912057-02-010026.txt#2963 Input fundies:CapitalExpenditure: 299114 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/880259/0000912057-02-010026.txt#2963
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2001 2001-01-01 – 2001-12-31

Revenue USD 689,773 100% of revenue
Operating costs Derived USD 43.72 million 6,339% of revenue
Operating income −USD 43.03 million −6,239% of revenue
Tax, interest and other Derived −USD 387,678 −56% of revenue
Net income −USD 42.65 million −6,183% of revenue

Cash

Operating cash flow −USD 13.12 million −1,901% of revenue
Capital expenditure USD 1.14 million 165% of revenue
Free cash flow Derived −USD 14.25 million −2,066% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1996 Not shown: operating income or net income is not reported.
1997 Not shown: operating income or net income is not reported.
1998 Not shown: operating income or net income is not reported.
1999 Operating loss: operating costs were 209% of revenue.
2000 Operating loss: operating costs were 384% of revenue.
2001 Operating loss: operating costs were 6,339% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1996 1996-01-01 – 1996-12-31	3163315	Unavailable	Unavailable	Unavailable	-11268042	-10733453 Derived	Source 1996-01-01 – 1996-12-31: 3163315 USD Inspect Revenue Open source 1996-01-01 – 1996-12-31: -11268042 USD Inspect Net Income Open source 1996-01-01 – 1996-12-31: -9280642 USD Inspect Operating Cash Flow Open source 1996-01-01 – 1996-12-31: 1452811 USD Inspect Capital Expenditure Open source
1997 1997-01-01 – 1997-12-31	10043475000	Unavailable	Unavailable	Unavailable	-2087239000	Unavailable	Source 1997-01-01 – 1997-12-31: 10043475000 USD Inspect Revenue Open source 1997-01-01 – 1997-12-31: -2087239000 USD Inspect Net Income Open source
1998 1998-01-01 – 1998-12-31	9046143	Unavailable	Unavailable	Unavailable	-6037108	-6403554 Derived	Source 1998-01-01 – 1998-12-31: 9046143 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: -6037108 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: -6280419 USD Inspect Operating Cash Flow Open source 1998-01-01 – 1998-12-31: 123135 USD Inspect Capital Expenditure Open source
1999 1999-01-01 – 1999-12-31	8688475	18126193 Derived	-9437718	-764268 Derived	-8673450	-6694597 Derived	Source 1999-01-01 – 1999-12-31: 8688475 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: -9437718 USD Inspect Operating Income Open source 1999-01-01 – 1999-12-31: -8673450 USD Inspect Net Income Open source 1999-01-01 – 1999-12-31: -6277758 USD Inspect Operating Cash Flow Open source 1999-01-01 – 1999-12-31: 416839 USD Inspect Capital Expenditure Open source
2000 2000-01-01 – 2000-12-31	4563475	17517343 Derived	-12953868	-1274505 Derived	-11679363	-16709548 Derived	Source 2000-01-01 – 2000-12-31: 4563475 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: -12953868 USD Inspect Operating Income Open source 2000-01-01 – 2000-12-31: -11679363 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: -16410434 USD Inspect Operating Cash Flow Open source 2000-01-01 – 2000-12-31: 299114 USD Inspect Capital Expenditure Open source
2001 2001-01-01 – 2001-12-31	689773	43723042 Derived	-43033269	-387678 Derived	-42645591	-14252955 Derived	Source 2001-01-01 – 2001-12-31: 689773 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: -43033269 USD Inspect Operating Income Open source 2001-01-01 – 2001-12-31: -42645591 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: -13115605 USD Inspect Operating Cash Flow Open source 2001-01-01 – 2001-12-31: 1137350 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 689.8K 2001

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19961996-12-31	Revenue	3163315	Revenue: 3163315 Open source
19971997-12-31	Revenue	10043475000	Revenue: 10043475000 Open source
19981998-12-31	Revenue	9046143	Revenue: 9046143 Open source
19991999-12-31	Revenue	8688475	Revenue: 8688475 Open source
20002000-12-31	Revenue	4563475	Revenue: 4563475 Open source
20012001-12-31	Revenue	689773	Revenue: 689773 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-84.9% 2001

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19961996-12-31	Year over year	No prior comparable period	Revenue: 3163315 Open source
19971997-12-31	Year over year	317,398.4%	Revenue: 10043475000 Open source Revenue: 3163315 Open source
19981998-12-31	Year over year	-99.9%	Revenue: 9046143 Open source Revenue: 10043475000 Open source
19991999-12-31	Year over year	-4%	Revenue: 8688475 Open source Revenue: 9046143 Open source
20002000-12-31	Year over year	-47.5%	Revenue: 4563475 Open source Revenue: 8688475 Open source
20012001-12-31	Year over year	-84.9%	Revenue: 689773 Open source Revenue: 4563475 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -6,238.8% 2001

Net margin -6,182.6% 2001

Free cash flow margin -2,066.3% 2001

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
1996-12-31	Operating margin	Not reported	Revenue: 3163315 Open source
1997-12-31	Operating margin	Not reported	Revenue: 10043475000 Open source
1998-12-31	Operating margin	Not reported	Revenue: 9046143 Open source
19991999-12-31	Operating margin	-108.6%	Operating Income: -9437718 Open source Revenue: 8688475 Open source
20002000-12-31	Operating margin	-283.9%	Operating Income: -12953868 Open source Revenue: 4563475 Open source
20012001-12-31	Operating margin	-6,238.8%	Operating Income: -43033269 Open source Revenue: 689773 Open source
19961996-12-31	Net margin	-356.2%	Net Income: -11268042 Open source Revenue: 3163315 Open source
19971997-12-31	Net margin	-20.8%	Net Income: -2087239000 Open source Revenue: 10043475000 Open source
19981998-12-31	Net margin	-66.7%	Net Income: -6037108 Open source Revenue: 9046143 Open source
19991999-12-31	Net margin	-99.8%	Net Income: -8673450 Open source Revenue: 8688475 Open source
20002000-12-31	Net margin	-255.9%	Net Income: -11679363 Open source Revenue: 4563475 Open source
20012001-12-31	Net margin	-6,182.6%	Net Income: -42645591 Open source Revenue: 689773 Open source
19961996-12-31	Free cash flow margin	-339.3%	Revenue: 3163315 Open source Operating Cash Flow: -9280642 Open source Capital Expenditure: 1452811 Open source
19971997-12-31	Free cash flow margin	Not reported	Revenue: 10043475000 Open source
19981998-12-31	Free cash flow margin	-70.8%	Revenue: 9046143 Open source Operating Cash Flow: -6280419 Open source Capital Expenditure: 123135 Open source
19991999-12-31	Free cash flow margin	-77.1%	Revenue: 8688475 Open source Operating Cash Flow: -6277758 Open source Capital Expenditure: 416839 Open source
20002000-12-31	Free cash flow margin	-366.2%	Revenue: 4563475 Open source Operating Cash Flow: -16410434 Open source Capital Expenditure: 299114 Open source
20012001-12-31	Free cash flow margin	-2,066.3%	Revenue: 689773 Open source Operating Cash Flow: -13115605 Open source Capital Expenditure: 1137350 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -13.1M 2001

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19961996-12-31	Operating cash flow	-9280642	Operating Cash Flow: -9280642 Open source
19971997-12-31	Operating cash flow	Not reported	No source recorded
19981998-12-31	Operating cash flow	-6280419	Operating Cash Flow: -6280419 Open source
19991999-12-31	Operating cash flow	-6277758	Operating Cash Flow: -6277758 Open source
20002000-12-31	Operating cash flow	-16410434	Operating Cash Flow: -16410434 Open source
20012001-12-31	Operating cash flow	-13115605	Operating Cash Flow: -13115605 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -14.3M 2001

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19961996-12-31	Free cash flow	-10733453	Operating Cash Flow: -9280642 Open source Capital Expenditure: 1452811 Open source
19971997-12-31	Free cash flow	Unavailable	No source recorded
19981998-12-31	Free cash flow	-6403554	Operating Cash Flow: -6280419 Open source Capital Expenditure: 123135 Open source
19991999-12-31	Free cash flow	-6694597	Operating Cash Flow: -6277758 Open source Capital Expenditure: 416839 Open source
20002000-12-31	Free cash flow	-16709548	Operating Cash Flow: -16410434 Open source Capital Expenditure: 299114 Open source
20012001-12-31	Free cash flow	-14252955	Operating Cash Flow: -13115605 Open source Capital Expenditure: 1137350 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1996-12-31	Liabilities / assets	Not reported	Total Assets: 32315635 Open source
1997-12-31	Liabilities / assets	Not reported	Total Assets: 20567549 Open source
1998-12-31	Liabilities / assets	Not reported	Total Assets: 20801550 Open source
1999-12-31	Liabilities / assets	Not reported	Total Assets: 21208982 Open source
2000-12-31	Liabilities / assets	Not reported	Total Assets: 17157965 Open source
2001-12-31	Liabilities / assets	Not reported	Total Assets: 49738985 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.99× 2001

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
19961996-12-31	Current assets / current liabilities	7.21×	Current Assets: 20652945 Open source Current Liabilities: 2864953 Open source
19971997-12-31	Current assets / current liabilities	9.08×	Current Assets: 19565864 Open source Current Liabilities: 2155410 Open source
19981998-12-31	Current assets / current liabilities	1.98×	Current Assets: 19340126 Open source Current Liabilities: 9771237 Open source
19991999-12-31	Current assets / current liabilities	6.87×	Current Assets: 19892821 Open source Current Liabilities: 2893679 Open source
20002000-12-31	Current assets / current liabilities	6.55×	Current Assets: 15715759 Open source Current Liabilities: 2400679 Open source
20012001-12-31	Current assets / current liabilities	2.99×	Current Assets: 17191934 Open source Current Liabilities: 5758642 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1996 1996-01-01 – 1996-12-31	−USD 11.27 million Exact value Exact value: -11268042 USD 1996-01-01 – 1996-12-31: -11268042 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOTRANSPLANT INC · 1996-12-31 BIOTRANSPLANT INC (edgar:880259) Net Income: -11268042 USD Concept: fundies:NetIncome Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/880259/explain?concept=fundies%3ANetIncome&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:NetIncome: -11268042 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/880259/0000950135-97-001390.txt#2463 The citation records this snapshot. The page link may show a newer release later.	−USD 9.28 million Exact value Exact value: -9280642 USD 1996-01-01 – 1996-12-31: -9280642 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOTRANSPLANT INC · 1996-12-31 BIOTRANSPLANT INC (edgar:880259) Operating Cash Flow: -9280642 USD Concept: fundies:OperatingCashFlow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/880259/explain?concept=fundies%3AOperatingCashFlow&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9280642 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/880259/0000950135-97-001390.txt#2479 The citation records this snapshot. The page link may show a newer release later.	USD 1.45 million Exact value Exact value: 1452811 USD 1996-01-01 – 1996-12-31: 1452811 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOTRANSPLANT INC · 1996-12-31 BIOTRANSPLANT INC (edgar:880259) Capital Expenditure: 1452811 USD Concept: fundies:CapitalExpenditure Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/880259/explain?concept=fundies%3ACapitalExpenditure&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1452811 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/880259/0000950135-97-001390.txt#2482 The citation records this snapshot. The page link may show a newer release later.	−USD 10.73 million Calculation and evidence -9280642 − 1452811 USD Exact free cash flow: -10733453 USD 1996-01-01 – 1996-12-31: -9280642 USD · Inspect Operating Cash Flow · Source 1996-01-01 – 1996-12-31: 1452811 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOTRANSPLANT INC · 1996-12-31 BIOTRANSPLANT INC (edgar:880259) Free cash flow: -10733453 USD Concept: free-cash-flow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/880259?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9280642 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/880259/0000950135-97-001390.txt#2479 Input fundies:CapitalExpenditure: 1452811 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/880259/0000950135-97-001390.txt#2482 The citation records this snapshot. The page link may show a newer release later.
1997 1997-01-01 – 1997-12-31	−USD 2.09 billion Exact value Exact value: -2087239000 USD 1997-01-01 – 1997-12-31: -2087239000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOTRANSPLANT INC · 1997-12-31 BIOTRANSPLANT INC (edgar:880259) Net Income: -2087239000 USD Concept: fundies:NetIncome Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/880259/explain?concept=fundies%3ANetIncome&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2087239000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/880259/0001047469-98-012122.txt#2722 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
1998 1998-01-01 – 1998-12-31	−USD 6.04 million Exact value Exact value: -6037108 USD 1998-01-01 – 1998-12-31: -6037108 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOTRANSPLANT INC · 1998-12-31 BIOTRANSPLANT INC (edgar:880259) Net Income: -6037108 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/880259/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: -6037108 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/880259/0001047469-99-012560.txt#2403 The citation records this snapshot. The page link may show a newer release later.	−USD 6.28 million Exact value Exact value: -6280419 USD 1998-01-01 – 1998-12-31: -6280419 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOTRANSPLANT INC · 1998-12-31 BIOTRANSPLANT INC (edgar:880259) Operating Cash Flow: -6280419 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/880259/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6280419 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/880259/0001047469-99-012560.txt#2418 The citation records this snapshot. The page link may show a newer release later.	USD 123,135 Exact value Exact value: 123135 USD 1998-01-01 – 1998-12-31: 123135 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOTRANSPLANT INC · 1998-12-31 BIOTRANSPLANT INC (edgar:880259) Capital Expenditure: 123135 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/880259/explain?concept=fundies%3ACapitalExpenditure&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 123135 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/880259/0001047469-99-012560.txt#2421 The citation records this snapshot. The page link may show a newer release later.	−USD 6.4 million Calculation and evidence -6280419 − 123135 USD Exact free cash flow: -6403554 USD 1998-01-01 – 1998-12-31: -6280419 USD · Inspect Operating Cash Flow · Source 1998-01-01 – 1998-12-31: 123135 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOTRANSPLANT INC · 1998-12-31 BIOTRANSPLANT INC (edgar:880259) Free cash flow: -6403554 USD Concept: free-cash-flow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/880259?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6280419 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/880259/0001047469-99-012560.txt#2418 Input fundies:CapitalExpenditure: 123135 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/880259/0001047469-99-012560.txt#2421 The citation records this snapshot. The page link may show a newer release later.
1999 1999-01-01 – 1999-12-31	−USD 8.67 million Exact value Exact value: -8673450 USD 1999-01-01 – 1999-12-31: -8673450 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOTRANSPLANT INC · 1999-12-31 BIOTRANSPLANT INC (edgar:880259) Net Income: -8673450 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/880259/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8673450 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/880259/0000912057-02-010026.txt#2940 The citation records this snapshot. The page link may show a newer release later.	−USD 6.28 million Exact value Exact value: -6277758 USD 1999-01-01 – 1999-12-31: -6277758 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOTRANSPLANT INC · 1999-12-31 BIOTRANSPLANT INC (edgar:880259) Operating Cash Flow: -6277758 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/880259/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6277758 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/880259/0000912057-02-010026.txt#2959 The citation records this snapshot. The page link may show a newer release later.	USD 416,839 Exact value Exact value: 416839 USD 1999-01-01 – 1999-12-31: 416839 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOTRANSPLANT INC · 1999-12-31 BIOTRANSPLANT INC (edgar:880259) Capital Expenditure: 416839 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/880259/explain?concept=fundies%3ACapitalExpenditure&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 416839 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/880259/0000912057-02-010026.txt#2963 The citation records this snapshot. The page link may show a newer release later.	−USD 6.69 million Calculation and evidence -6277758 − 416839 USD Exact free cash flow: -6694597 USD 1999-01-01 – 1999-12-31: -6277758 USD · Inspect Operating Cash Flow · Source 1999-01-01 – 1999-12-31: 416839 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOTRANSPLANT INC · 1999-12-31 BIOTRANSPLANT INC (edgar:880259) Free cash flow: -6694597 USD Concept: free-cash-flow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/880259?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6277758 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/880259/0000912057-02-010026.txt#2959 Input fundies:CapitalExpenditure: 416839 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/880259/0000912057-02-010026.txt#2963 The citation records this snapshot. The page link may show a newer release later.
2000 2000-01-01 – 2000-12-31	−USD 11.68 million Exact value Exact value: -11679363 USD 2000-01-01 – 2000-12-31: -11679363 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOTRANSPLANT INC · 2000-12-31 BIOTRANSPLANT INC (edgar:880259) Net Income: -11679363 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/880259/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: -11679363 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/880259/0000912057-02-010026.txt#2940 The citation records this snapshot. The page link may show a newer release later.	−USD 16.41 million Exact value Exact value: -16410434 USD 2000-01-01 – 2000-12-31: -16410434 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOTRANSPLANT INC · 2000-12-31 BIOTRANSPLANT INC (edgar:880259) Operating Cash Flow: -16410434 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/880259/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -16410434 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/880259/0000912057-02-010026.txt#2959 The citation records this snapshot. The page link may show a newer release later.	USD 299,114 Exact value Exact value: 299114 USD 2000-01-01 – 2000-12-31: 299114 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOTRANSPLANT INC · 2000-12-31 BIOTRANSPLANT INC (edgar:880259) Capital Expenditure: 299114 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/880259/explain?concept=fundies%3ACapitalExpenditure&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 299114 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/880259/0000912057-02-010026.txt#2963 The citation records this snapshot. The page link may show a newer release later.	−USD 16.71 million Calculation and evidence -16410434 − 299114 USD Exact free cash flow: -16709548 USD 2000-01-01 – 2000-12-31: -16410434 USD · Inspect Operating Cash Flow · Source 2000-01-01 – 2000-12-31: 299114 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOTRANSPLANT INC · 2000-12-31 BIOTRANSPLANT INC (edgar:880259) Free cash flow: -16709548 USD Concept: free-cash-flow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/880259?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -16410434 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/880259/0000912057-02-010026.txt#2959 Input fundies:CapitalExpenditure: 299114 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/880259/0000912057-02-010026.txt#2963 The citation records this snapshot. The page link may show a newer release later.
2001 2001-01-01 – 2001-12-31	−USD 42.65 million Exact value Exact value: -42645591 USD 2001-01-01 – 2001-12-31: -42645591 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOTRANSPLANT INC · 2001-12-31 BIOTRANSPLANT INC (edgar:880259) Net Income: -42645591 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/880259/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -42645591 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/880259/0000912057-02-010026.txt#2940 The citation records this snapshot. The page link may show a newer release later.	−USD 13.12 million Exact value Exact value: -13115605 USD 2001-01-01 – 2001-12-31: -13115605 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOTRANSPLANT INC · 2001-12-31 BIOTRANSPLANT INC (edgar:880259) Operating Cash Flow: -13115605 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/880259/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13115605 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/880259/0000912057-02-010026.txt#2959 The citation records this snapshot. The page link may show a newer release later.	USD 1.14 million Exact value Exact value: 1137350 USD 2001-01-01 – 2001-12-31: 1137350 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOTRANSPLANT INC · 2001-12-31 BIOTRANSPLANT INC (edgar:880259) Capital Expenditure: 1137350 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/880259/explain?concept=fundies%3ACapitalExpenditure&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1137350 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/880259/0000912057-02-010026.txt#2963 The citation records this snapshot. The page link may show a newer release later.	−USD 14.25 million Calculation and evidence -13115605 − 1137350 USD Exact free cash flow: -14252955 USD 2001-01-01 – 2001-12-31: -13115605 USD · Inspect Operating Cash Flow · Source 2001-01-01 – 2001-12-31: 1137350 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BIOTRANSPLANT INC · 2001-12-31 BIOTRANSPLANT INC (edgar:880259) Free cash flow: -14252955 USD Concept: free-cash-flow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T18:15:16Z Snapshot: 55076fd57ed3cca794769d5b0e9517a0bd154bd0746b7f170c13cdba6bc5e141 Dimensions: Consolidated View: https://fundies.io/companies/edgar/880259?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13115605 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/880259/0000912057-02-010026.txt#2959 Input fundies:CapitalExpenditure: 1137350 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/880259/0000912057-02-010026.txt#2963 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

30 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000880259, 880259, edgar:880259

BIOTRANSPLANT INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2001 2001-01-01 – 2001-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation